The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
Approval Biosimilar Notice Implicates Millions
1 min
Related Services
Related Insights
How a Surge of PGRs for Biologics Could Challenge PTAB Counsel
How a Surge of PGRs for Biologics Could Challenge PTAB Counsel
July 28, 2021
1min
Venable Fitzpatrick’s BiologicsHQ Monthly Injection – June 2021
Venable Fitzpatrick’s BiologicsHQ Monthly Injection – June 2021
July 13, 2021
1min
Supreme Court Upholds ACA for Third Time, but New Threats Loom
Supreme Court Upholds ACA for Third Time, but New Threats Loom
June 29, 2021
1min
Recent News
San Francisco Business Times Recognizes Venable Among the Region’s 2021 Top Corporate Philanthropists
San Francisco Business Times Recognizes Venable Among the Region’s 2021 Top Corporate Philanthropists
July 29, 2021
1min
Daily Journal Recognizes Jean-Paul Cart Among Its Top 40 Under 40 for 2021
Daily Journal Recognizes Jean-Paul Cart Among Its Top 40 Under 40 for 2021
July 28, 2021
1min
Venable Welcomes Jennifer Reddien as the Firm's Inaugural Chief Diversity and Inclusion Officer
Venable Welcomes Jennifer Reddien as the Firm's Inaugural Chief Diversity and Inclusion Officer
July 27, 2021
3min